Pasithea Therapeutics Corp. (KTTA)
0.7305
+0.02
(+2.17%)
USD |
NASDAQ |
Mar 31, 10:36
Pasithea Therapeutics EPS Diluted (Quarterly) : -0.4081 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.037M |
| Total Expenses (Quarterly) | 3.037M |
| Enterprise Value | 1.138M |
| Earnings Yield | -695.7% |
| Normalized Earnings Yield | -699.63 |